rituximab/cyclophosphamide/doxorubicin/vincristine (Oncocin)/prednisone (R-CHOP)
Jump to navigation
Jump to search
Indications
- chemotherapy regimen for treatment of lymphomas
Dosage
- six 21-day cycles
- rituximab (375 mg/m2) administered on day 1 of each cycle
- on days 1-5
- cyclophosphamide (400 mg/m2)
- doxorubicin (25 mg/m2)
- vincristine (1 mg capped dose)
- prednisone (40 mg/m2)
More general terms
Additional terms
Components
- rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)
- vincristine; 22-oxovincaleukoblastine; leurocristine (Oncovin, Vincasar PFS)
- doxorubicin (Adriamycin, Rubex)
- cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
- prednisone (Deltasone, Orasone, Liquid Pred, Meticortin, Rayos)
References
- ↑ Peyrade F et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: A multicentre, single-arm, phase 2 trial. Lancet Oncol 2011 May; 12:460 http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(11)70069-9/fulltext